Avreo (formerly Riptide Technologies) and A-Life Medical have entered into an OEM partnership to integrate A-Life's LifeCode technology into Avreo's ARIIS (advanced radiology integrated Internet solution), both XML-native systems. LifeCode,
Avreo (formerly Riptide Technologies) and A-Life Medical have entered into an OEM partnership to integrate A-Life's LifeCode technology into Avreo's ARIIS (advanced radiology integrated Internet solution), both XML-native systems. LifeCode, based on natural language processing, provides real-time code generation and compliance checking. Avreo intends to use the LifeCode engine to add voice recognition functionality to ARIIS, giving radiologists immediate feedback regarding diagnostic reports. The firms will demonstrate the integrated products at the RSNA meeting.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.